Anti-Dardarin/LRRK2, C-Terminus Antibody (N241A/34)
Primary Antibody
Human, Mouse, Rat
N241A/34
ICC, IHC, WB
Mouse
Purified
LRRK2 PARK8
>200 kDa
Adult rat brain immunohistochemistry (with antigen retrieval via sodium citrate pretreatment).
- Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y, Takao M, Wauters S, van de Berg WD, Takahashi-Fujigasaki J, Nichols RJ, Holton JL, Murayama S, Halliday GM. (2017), 'LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies..' Mov Disord.. 10.1002/mds.26892.
- Schwab AJ, Ebert AD. (2015), 'Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson's Disease-Related LRRK2 G2019S Mutation..' Stem Cell Reports.. 10.1016/j.stemcr.2015.11.004.
- Choi I, Kim B, Byun JW, Baik SH, Huh YH, Kim JH, Mook-Jung I, Song WK, Shin JH, Seo H, Suh YH, Jou I, Park SM, Kang HC, Joe EH,. (2015), 'LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase..' Nat Commun.. 10.1038/ncomms9255.
- Zhao J, Molitor TP, Langston JW, Nichols RJ. (2015), 'LRRK2 dephosphorylation increases its ubiquitination.' Biochem J.. 10.1042/BJ20141305.
- Boddu R, Hull TD, Bolisetty S, Hu X, Moehle MS, Daher JP, Kamal AI, Joseph R, George JF, Agarwal A, Curtis LM, West AB. (2015), 'Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury..' Hum Mol Genet.. 10.1093/hmg/ddv147.
- Henry AG, Aghamohammadzadeh S, Samaroo H, Chen Y, Mou K, Needle E, Hirst WD. (2015), 'Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression..' Hum Mol Genet.. 10.1093/hmg/ddv314.
- Fuji RN, Flagella M, Baca M, Baptista MA, Brodbeck J, Chan BK, Fiske BK, Honigberg L, Jubb AM, Katavolos P, Lee DW, Lewin-Koh SC, Lin T, Liu X, Liu S, Lyssikatos JP, O'Mahony J, Reichelt M, Roose-Girma M, Sheng Z, Sherer T, Smith A, Solon M, Sweeney ZK, Tarrant J, Urkowitz A, Warming S, Yaylaoglu M, Zhang S, Zhu H, Estrada AA, Watts RJ. (2015), 'Effect of selective LRRK2 kinase inhibition on nonhuman primate lung..' Sci Transl Med.. 10.1126/scitranslmed.aaa3634.
- Lee JW, Tapias V, Di Maio R, Greenamyre JT, Cannon JR. (2015), 'Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats..' Neurobiol Aging.. 10.1016/j.neurobiolaging.2014.07.011.
- West AB, Cowell RM, Daher JP, Moehle MS, Hinkle KM, Melrose HL, Standaert DG, Volpicelli-Daley LA. (2014), 'Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents..' J Comp Neurol.. 10.1002/cne.23583.
- Liu Z, Galemmo RA Jr, Fraser KB, Moehle MS, Sen S, Volpicelli-Daley LA, DeLucas LJ, Ross LJ, Valiyaveettil J, Moukha-Chafiq O, Pathak AK, Ananthan S, Kezar H, White EL, Gupta V, Maddry JA, Suto MJ, West AB. (2014), 'Unique functional and structural properties of the LRRK2 protein ATP-binding pocket..' J Biol Chem.. 10.1074/jbc.M114.602318.
- Gómez-Suaga P, Rivero-Ríos P, Fdez E, Blanca Ramírez M, Ferrer I, Aiastui A, López De Munain A, Hilfiker S. (2014), 'LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity..' Hum Mol Genet.. 10.1093/hmg/ddu395.
- Daher JP, Volpicelli-Daley LA, Blackburn JP, Moehle MS, West AB. (2014), 'Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats..' Proc Natl Acad Sci U S A.. 10.1073/pnas.1403215111.
- Schapansky J, Nardozzi JD, Felizia F, LaVoie MJ. (2014), 'Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy..' Hum Mol Genet.. 10.1093/hmg/ddu138.
- Dorval V, Mandemakers W, Jolivette F, Coudert L, Mazroui R, De Strooper B, Hébert SS. (2014), 'Gene and MicroRNA transcriptome analysis of Parkinson's related LRRK2 mouse models..' PLoS One.. 10.1371/journal.pone.0085510.
- Stafa K, Tsika E, Moser R, Musso A, Glauser L, Jones A, Biskup S, Xiong Y, Bandopadhyay R, Dawson VL, Dawson TM, Moore DJ. (2014), 'Functional interaction of Parkinson's disease-associated LRRK2 with members of the dynamin GTPase superfamily..' Hum Mol Genet.. 10.1093/hmg/ddt600.
- Davies P, Hinkle KM, Sukar NN, Sepulveda B, Mesias R, Serrano G, Alessi DR, Beach TG, Benson DL, White CL, Cowell RM, Das SS, West AB, Melrose HL. (2013), 'Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies..' Biochem J.. 10.1042/BJ20121742.
- Yao C, Johnson WM, Gao Y, Wang W, Zhang J, Deak M, Alessi DR, Zhu X, Mieyal JJ, Roder H, Wilson-Delfosse AL, Chen SG. (2013), 'Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity..' Hum Mol Genet.. 10.1093/hmg/dds431.
- Gómez-Suaga P, Luzón-Toro B, Churamani D, Zhang L, Bloor-Young D, Patel S, Woodman PG, Churchill GC, Hilfiker S. (2012), 'Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP..' Hum Mol Genet.. 10.1093/hmg/ddr481.